𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Increased DNA methylation in the HoxA5 promoter region correlates with decreased expression of the gene during tumor promotion

✍ Scribed by Rebecca E. Watson; Geoffrey M. Curtin; Gary M. Hellmann; David J. Doolittle; Jay I. Goodman


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
478 KB
Volume
41
Category
Article
ISSN
0899-1987

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Promoter‐region DNA methylation inhibits transcription. A two‐stage SENCAR (__sen__sitive to mouse __car__cinogenesis) mouse skin carcinogenicity model was used to examine gene‐specific changes in methylation during skin tumor promotion. Analysis was performed on 7,12‐dimethylbenz[a]anthracene (DMBA)‐initiated skin promoted with 9, 18, 27, or 36 mg cigarette smoke condensate (CSC) for 9 wk, or 27 mg CSC for 9 wk and sacrificed 6 wk afterwards (recovery group). Additionally, tumors arising following promotion with 27 mg CSC for 29 wk were assessed. Gene array analysis identified differentially expressed genes. Expression of HoxA5, a tumor suppressor gene, was decreased following 9 wk of treatment with 27 mg CSC, and returned to control levels during recovery. HoxA5 promoter methylation was measured with the enzymatic regional methylation assay (ERMA). DNA was bisulfite‐modified, PCR‐amplified with primers containing dam sites, incubated with [^14^C‐methyl] S‐adenosyl‐l‐methionine (SAM) and dam methyltransferase for DNA quantification, then incubated with [^3^H‐methyl] SAM and SssI methylase to quantify methylation status. Higher ^3^H/^14^C ratios indicate increased methylation. The ^3^H/^14^C ratios of animals promoted with 27 or 36 mg CSC (48.2 ± 6.9 and 24.2 ± 6.1, respectively) were higher than the control or recovery group ratios (12.3 ± 0.1 and 12.6 ± 0.3, respectively); sequence analysis supported these findings. Increased methylation of p16 or O^6^ methylguanine methyltranferase (MGMT) was detected in 4/8 (50%) of the tumor samples from mice promoted with 27 mg CSC. These data suggest that increased DNA methylation contributes to the downregulation of HoxA5, and combined with hypermethylation of p16 or MGMT, this might facilitate the clonal expansion of increasingly aberrant cells during promotion. © 2004 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Expression of the p16INK4a gene and meth
✍ Kanya Honoki; Toshifumi Tsujiuchi; Toshio Mori; Kazuhiro Yoshitani; Masahiro Tsu 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

## Abstract Loss of p16^INK4a^ protein expression has frequently been related to DNA methylation in association with gene silencing. Although the methylation status of exon1α for p16^INK4a^ involvement in various cancers has been extensively analyzed, it has been pointed out that some inconsistenci

Methylation of the O6-methylguanine-DNA
✍ Rana Abdel-Fattah; Adam Glick; Ishtiaq Rehman; Patrick Maiberger; Henry Hennings 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 212 KB

## Abstract Hypermethylation of CpG sites within the promoter region of the __O^6^‐methylguanine‐DNA methyltransferase__ (__MGMT__) gene occurs frequently in human cancer, preventing both MGMT expression and repair of alkylation damage. To assess the role of MGMT in the development of mouse skin tu

Developmentally specific effects of the
✍ Rosemary M. Caron; Joshua W. Hamilton 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 234 KB 👁 1 views

## Previous studies in our laboratory have demonstrated that genotoxic chemical carcinogens have strong preferential effects on expression of certain inducible genes at nonovertly toxic doses in vivo. The effects of the DNA cross-linking agent and chemotherapy drug, mitomycin C (MMC), on expressio